10/09/2020
Associate Professor Shuan Dai is leading a two-year Australian-first study using artificial intelligence (AI) to diagnose one of the leading causes of infant blindness.
Plus disease is a severe type of retinopathy of prematurity (ROP), caused by abnormal development of retinal blood vessels in premature infants.
The disease currently affects about 3,000 Australian children, but can can be prevented if it is detected and treated early. The study aims to use an AI solution where specialist ophthalmologists are not readily available to automatically detect plus disease.
The technology will provide children in regional and remote areas of Queensland more equitable access to treatment, offering timely diagnosis that has the potential to save their sight. The study, funded by the Children's Hospital Foundation, will include a collaboration of experts from hospitals and universities in Queensland, New South Wales, Victoria, Perth and New Zealand.